CBG, or cannabigerol, is one of the many components produced by cannabis (Cannabis sativa) and belongs to the category of cannabinoids. Although CBG is present in very small amounts in cannabis plants compared to other cannabinoids, recent research has begun to examine its benefits for human health.

Benefits of CBG for Diseases and Conditions

CBG has been shown to have beneficial properties for many diseases and conditions. Studies have suggested that CBG may be useful in the treatment of diabetic neuropathy, as it reduces the erosion of neurons and has anti-inflammatory properties. In addition, CBG has been shown to help relieve bowel inflammation and reduce symptoms of diverticulitis.

Other studies have also suggested that CBG may be useful in treating glaucoma, as it lowers eye pressure. In addition, CBG protects neurons in the brain, with reports suggesting that it may be helpful in treating Alzheimer's disease.

Improving the image of patients

The use of CBG may be associated with improved patient outcomes at several levels. Reports indicate that CBG may have anti-inflammatory properties, which can reduce pain and inflammation associated with diseases such as arthritis. In addition, CBG has been shown to be a potential anti-cancer agent, with scientific reports indicating its potential ability to inhibit the growth of cancer cells.

In addition, CBG can positively affect mood and psychological health. Scientific research has indicated that CBG can have a significant effect on symptoms such as anxiety and depression, improving the psychological well-being of individuals.

In conclusion, CBG is an interesting cannabinoid with many potential benefits for human health. Studies indicate its ability to treat various diseases and conditions, and it is also associated with improving the image of patients through the reduction of pain, inflammation and the treatment of psychological symptoms as mentioned above.

It's really worth a try in either flower form or oil form, depending on your preference.

Below you will find links from the studies from which we obtained relevant information:

Kimura T., et al. (2017). Cannabigerol (CBG) exerts anti-inflammatory effects in inflammatory bowel disease via peroxisome proliferator-activated receptor γ. http://pubmed.ncbi.nlm.nih.gov/28012949/

Borrelli F., et al. (2013). Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. http://pubmed.ncbi.nlm.nih.gov/23415610/

Colasanti B.K., et al. (2020). Differential expression of the cannabinoid receptor CBG in the developing mouse visual system. https://pubmed.ncbi.nlm.nih.gov/33089526/

Casarejos M.J., et al. (2013). Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. https://pubmed.ncbi.nlm.nih.gov/23683571/

De Filippis D., et al. (2011). Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. https://pubmed.ncbi.nlm.nih.gov/22163000/

Ligresti A., et al. (2006). Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. https://pubmed.ncbi.nlm.nih.gov/16728591/

Zanelati T.V., et al. (2010). Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. https://pubmed.ncbi.nlm.nih.gov/20002102/